Zhuajin Bi
6PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 16, 2026
Efgartigimod for Guillain-Barré syndrome: a retrospective analysis of efficacy and safety.Zhuajin Bi, Xiaodong Ye, Peidong Liu
|Aug 04, 2025
Efgartigimod as a Fast-Acting Add-On Therapy in Antibody-Mediated Autoimmune Encephalitis.Zhuajin Bi, Wenzhong Kang, Ruihan Liu
|Jun 23, 2025
Comparison of outcomes and postoperative immunotherapy between patients with non-thymomatous and thymomatous myasthenia gravis following thymectomy.Qing Zhang, XuanXuan Pan, Zhuajin Bi
|Jan 17, 2025
The JAK1/3 Inhibitor Tofacitinib Regulates Th Cell Profiles and Humoral Immune Responses in Myasthenia Gravis.Zhuajin Bi, Qing Zhang, Huajie Gao
|Sep 03, 2024
Predictive Factors for Poor Outcomes Associated with COVID-19 in a Retrospective Cohort of Myasthenia Gravis Patients.Zhuajin Bi, Huajie Gao, Jing Lin
|Sep 12, 2022
Remission and relapses of myasthenia gravis on long-term tacrolimus: a retrospective cross-sectional study of a Chinese cohort.Zhuajin Bi, Yayun Cao, Chenchen Liu
Pageof 1
